Development of novel treatments for hepatitis C
Development of novel treatments for hepatitis C
About this item
Full title
Development of novel treatments for hepatitis C
Author / Creator
Publisher
London: Elsevier Ltd
Journal title
The Lancet infectious diseases, 2009-02, Vol.9 (2), p.108-117
Language
English
Formats
Publication information
Publisher
London: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Hepatitis C virus (HCV) infection is a major and growing global health problem, affecting about 170 million people worldwide, and is a leading cause of liver cirrhosis and hepatocellular carcinoma. Currently, treatment is restricted to interferon alfa and ribavirin, which leads to a successful outcome in only about 50% of individuals. New e...
Alternative Titles
Full title
Development of novel treatments for hepatitis C
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_201609181
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_201609181
Other Identifiers
ISSN
1473-3099
E-ISSN
1474-4457
DOI
10.1016/S1473-3099(09)70020-9
